BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33085925)

  • 1. Prevalence of Malignancy and Histopathological Association of Bosniak Classification, Version 2019 Class III and IV Cystic Renal Masses.
    Tse JR; Shen L; Shen J; Yoon L; Kamaya A
    J Urol; 2021 Apr; 205(4):1031-1038. PubMed ID: 33085925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportion of malignancy in Bosniak classification of cystic renal masses version 2019 (v2019) classes: systematic review and meta-analysis.
    McGrath TA; Bai X; Kamaya A; Park KJ; Park MY; Tse JR; Wang H; McInnes MDF; Schieda N
    Eur Radiol; 2023 Feb; 33(2):1307-1317. PubMed ID: 35999371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosniak Classification version 2019: validation and comparison to original classification in pathologically confirmed cystic masses.
    Yan JH; Chan J; Osman H; Munir J; Alrasheed S; Flood TA; Schieda N
    Eur Radiol; 2021 Dec; 31(12):9579-9587. PubMed ID: 34019130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of the new Bosniak classification v.2019 in benign lesions prediction within the higher Bosniak cysts classes.
    Elbaset MA; Ashour R; Elgamal M; Elbatta A; Ghobrial FK; Abouelkheir RT; Mosbah A; Osman Y
    Urol Oncol; 2023 Oct; 41(10):434.e1-434.e7. PubMed ID: 37574368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Kinetics and Progression Rate of Bosniak Classification Version 2019 Class III and IV Cystic Renal Masses on Imaging Surveillance.
    Tse JR; Shen L; Shen J; Yoon L; Chung BI; Kamaya A
    AJR Am J Roentgenol; 2022 Aug; 219(2):244-253. PubMed ID: 35293234
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Bosniak Classification of cystic renal masses version 2019 assessed by CT and MRI.
    Chan J; Yan JH; Munir J; Osman H; Alrasheed S; McGrath T; Flood T; Schieda N
    Abdom Radiol (NY); 2021 Nov; 46(11):5268-5276. PubMed ID: 34390368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Bosniak Classification Version 2019 Class IIF Cystic Renal Masses at Imaging Surveillance.
    Shen L; Yoon L; Chung BI; Kamaya A; Tse JR
    AJR Am J Roentgenol; 2023 May; 220(5):705-717. PubMed ID: 36416398
    [No Abstract]   [Full Text] [Related]  

  • 8. Bosniak Classification of Cystic Renal Masses Version 2019: Comparison of Categorization Using CT and MRI.
    Tse JR; Shen J; Shen L; Yoon L; Kamaya A
    AJR Am J Roentgenol; 2021 Feb; 216(2):412-420. PubMed ID: 32755181
    [No Abstract]   [Full Text] [Related]  

  • 9. Stratification of cystic renal masses into benign and potentially malignant: applying machine learning to the bosniak classification.
    Miskin N; Qin L; Matalon SA; Tirumani SH; Alessandrino F; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2021 Jan; 46(1):311-318. PubMed ID: 32613401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy Rate, Histologic Grade, and Progression of Bosniak Category III and IV Complex Renal Cystic Lesions.
    Mousessian PN; Yamauchi FI; Mussi TC; Baroni RH
    AJR Am J Roentgenol; 2017 Dec; 209(6):1285-1290. PubMed ID: 28981360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosniak Classification Version 2019 of Cystic Renal Masses Assessed With MRI.
    Tse JR; Shen J; Yoon L; Kamaya A
    AJR Am J Roentgenol; 2020 Aug; 215(2):413-419. PubMed ID: 32515608
    [No Abstract]   [Full Text] [Related]  

  • 12. CT-based Bosniak classification of cystic renal lesions: is version 2019 an improvement on version 2005?
    Dana J; Gauvin S; Zhang M; Lotero J; Cassim C; Artho G; Bhatnagar SR; Tanguay S; Reinhold C
    Eur Radiol; 2023 Feb; 33(2):1297-1306. PubMed ID: 36048207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses.
    Shen L; Tse JR; Lemieux S; Yoon L; Mullane PC; Liang T; Davenport MS; Pedrosa I; Silverman SG
    Abdom Radiol (NY); 2023 Aug; 48(8):2636-2648. PubMed ID: 37202641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of Additional Clinical and Radiological Parameters for Discrimination of Malignancy in Bosniak 3 Cysts.
    Sefik E; Bozkurt IH; Oguzdogan GY; Çelik S; Basmaci I; Gorgel SN; Aydin E; Adibelli ZH; Vardar E; Gunlusoy B; Degirmenci T
    Urol Int; 2021; 105(1-2):118-123. PubMed ID: 33242872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasound and Contrast-Enhanced Computer Tomography.
    Lan L; Yang Y; Xu ZQ; Jin XC; Huang KT; Chen YX; Yang CX; Zhou M
    J Ultrasound Med; 2023 Dec; 42(12):2845-2858. PubMed ID: 37732901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosniak category IIF and III cystic renal lesions: outcomes and associations.
    Smith AD; Remer EM; Cox KL; Lieber ML; Allen BC; Shah SN; Herts BR
    Radiology; 2012 Jan; 262(1):152-60. PubMed ID: 22106359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and prospective validation of a novel weighted quantitative scoring system aimed at predicting the pathological features of cystic renal masses.
    Li Y; Dai C; Bian T; Zhou J; Xiang Z; He M; Huang J; Zhu Y; Hu X; Jiang S; Guo J; Wang H
    Eur Radiol; 2019 Apr; 29(4):1809-1819. PubMed ID: 30311030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI evaluation of complex renal cysts using the Bosniak classification: a comparison to CT.
    Ferreira AM; Reis RB; Kajiwara PP; Silva GE; Elias J; Muglia VF
    Abdom Radiol (NY); 2016 Oct; 41(10):2011-9. PubMed ID: 27271286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cyst masses (Bosniak category II-III) may be over evaluated by the Bosniak criteria based on MR findings.
    Zhong J; Cao F; Guan X; Chen J; Ding Z; Zhang M
    Medicine (Baltimore); 2017 Dec; 96(51):e9361. PubMed ID: 29390525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Bosniak classification in malignant tumor diagnosis: A single institution experience.
    Oh TH; Seo IY
    Investig Clin Urol; 2016 Mar; 57(2):100-5; discussion 105. PubMed ID: 26981591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.